AU2594500A - Methods for using mycobacterium tuberculosis molecules as immunological adjuvants - Google Patents

Methods for using mycobacterium tuberculosis molecules as immunological adjuvants

Info

Publication number: AU2594500A
Authority: AU; Australia
Prior art keywords: methods; mycobacterium tuberculosis; immunological adjuvants; molecules; tuberculosis molecules
Prior art date: 1998-12-24
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU25945/00A

Inventor

Yasir Skeiky

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Corixa Corp

Original Assignee

Corixa Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-12-24

Filing date

1999-12-21

Publication date

2000-07-31

1999-12-21 Application filed by Corixa Corp filed Critical Corixa Corp

2000-07-31 Publication of AU2594500A publication Critical patent/AU2594500A/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55544—Bacterial toxins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Mycology (AREA)
Epidemiology (AREA)
Immunology (AREA)
Medicinal Chemistry (AREA)
Microbiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

AU25945/00A 1998-12-24 1999-12-21 Methods for using mycobacterium tuberculosis molecules as immunological adjuvants Abandoned AU2594500A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US22041698A	1998-12-24	1998-12-24
US09220416		1998-12-24
PCT/US1999/030975 WO2000039301A2 (en)	1998-12-24	1999-12-23	Methods for using mycobacterium tuberculosis molecules as immunological adjuvants

Publications (1)

Publication Number	Publication Date
AU2594500A true AU2594500A (en)	2000-07-31

Family

ID=22823460

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU25945/00A Abandoned AU2594500A (en)	1998-12-24	1999-12-21	Methods for using mycobacterium tuberculosis molecules as immunological adjuvants

Country Status (4)

Country	Link
EP (1)	EP1141312A2 (en)
AU (1)	AU2594500A (en)
CA (1)	CA2356669A1 (en)
WO (1)	WO2000039301A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0003082D0 (en) *	2000-02-10	2000-03-29	Glaxo Group Ltd	Vaccine
WO2002004018A2 (en) *	2000-07-10	2002-01-17	Colorado State University Research Foundation	Mid-life vaccine and methods for boosting anti-mycobacterial immunity
NZ519667A (en) *	2002-06-19	2005-02-25	Univ Massey	A putative 23kDa lipoprotein from Mycobacterium paratuberculosis and its use in Johne's disease
DE60325586D1 (en) *	2003-08-22	2009-02-12	Axenoll Ag	Mycobacterial protein antigens for cancer therapy and vaccination
AU2005305869B2 (en)	2004-11-16	2010-12-09	Aeras Global Tb Vaccine Foundation	Multivalent vaccines comprising recombinant viral vectors
WO2008140478A2 (en) *	2006-11-01	2008-11-20	Immport Therapeutics, Inc.	Compositions and methods for immunodominant antigens

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2095855C (en) *	1990-11-08	2003-04-29	Graham A.W. Rook	Mycobacterium as adjuvant for antigens
ES2324529T3 (en) *	1995-09-01	2009-08-10	Corixa Corporation	COMPOUNDS FOR IMMUNOTHERAPY AND DIAGNOSIS OF TUBERCULOSIS.
US6290969B1 (en) *	1995-09-01	2001-09-18	Corixa Corporation	Compounds and methods for immunotherapy and diagnosis of tuberculosis
DK1449922T3 (en) *	1997-04-02	2007-12-03	Statens Seruminstitut	Nucleic acid fragments and polypeptide fragments derived from M. tuberculosis

1999
- 1999-12-21 AU AU25945/00A patent/AU2594500A/en not_active Abandoned
- 1999-12-23 WO PCT/US1999/030975 patent/WO2000039301A2/en not_active Ceased
- 1999-12-23 EP EP99968552A patent/EP1141312A2/en not_active Withdrawn
- 1999-12-23 CA CA002356669A patent/CA2356669A1/en not_active Abandoned

Also Published As

Publication number	Publication date
WO2000039301A2 (en)	2000-07-06
EP1141312A2 (en)	2001-10-10
WO2000039301A3 (en)	2001-05-03
WO2000039301A9 (en)	2001-10-18
CA2356669A1 (en)	2000-07-06

Publication	Publication Date	Title
AU3089399A (en)	1999-10-11	Double mutant enterotoxin for use as an adjuvant
AU4670897A (en)	1998-05-15	Methods for producing low binding surfaces
AUPP230698A0 (en)	1998-04-09	Back support
AUPO769197A0 (en)	1997-07-24	Dovetail jig
AU1583299A (en)	2000-05-29	Mechanical fastener device
AU3568799A (en)	1999-11-08	Booklet
AUPM543894A0 (en)	1994-05-26	An adjuvant
AU4041999A (en)	1999-11-29	Synchronous magneto
AU2594500A (en)	2000-07-31	Methods for using mycobacterium tuberculosis molecules as immunological adjuvants
AU7068598A (en)	1998-11-24	Clamps
AU1080899A (en)	1999-05-03	Methods for increasing schwann cell survival
AU3038697A (en)	1998-01-05	Meningococcal vaccine
AU2003199A (en)	1999-07-12	Lymphotactin as an adjuvant
AU2314099A (en)	1999-08-02	Secure exam method
AU9187898A (en)	2000-04-17	Disk device
AUPO108996A0 (en)	1996-08-08	Vibration isolation device
AU9188298A (en)	2000-04-17	Disk device
AU3593200A (en)	2000-08-29	(mycobacterium tuberculosis), immunization
AU2214597A (en)	1997-10-10	Methods for increasing or decreasing transfection efficiency
AU2659800A (en)	2000-05-22	Electromechanical component
AU6313498A (en)	1998-09-18	Sound synchronizing
AU6160599A (en)	2000-04-17	Vaccine based on attenuated (haemophilus somnus)
AUPP340198A0 (en)	1998-05-28	Immunological adjuvant
AU4102899A (en)	2000-03-06	Support aid
AU9188198A (en)	2000-04-17	Motor supporting device

Legal Events

Date	Code	Title	Description
2001-09-20	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase